Skip to content

IN-TANDEM Familial Hypercholesterolemia Pilot Study

INTegrating Active Case-finding With Next-generation Sequencing for Diagnosis Through Electronic Medical Records (IN-TANDEM): Familial Hypercholesterolemia Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03253432
Enrollment
378
Registered
2017-08-17
Start date
2017-07-20
Completion date
2018-11-07
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial Hypercholesterolemia

Brief summary

The purpose of this study is to validate the use of the FH Foundation FIND FH® Algorithm as a clinical decision support tool. FIND FH (Flag/Identify/Network/Engage) is a national initiative that utilizes machine learning and data mining techniques to identify individuals whose profiles are consistent with FH patients. The algorithm will be tested in adults with at least one cardiovascular comorbidity. Study subjects will be asked to provide either a saliva, buccal or venous blood sample for DNA and biomarker analysis

Interventions

OTHERGenetic testing

Targeted next-generation sequencing for familial hypercholesterolemia causative mutations

Sponsors

The Familial Hypercholesterolemia Foundation
CollaboratorOTHER
Lancaster General Hospital
CollaboratorOTHER
University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * At least one cardiovascular co-morbidity or receiving treatment for a cardiovascular comorbidity * Algorithm score 0-1 * Most recent encounter with a provider within five years of query date

Exclusion criteria

* Any medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety or successful participation in the study, or confound study data

Design outcomes

Primary

MeasureTime frameDescription
Likelihood of having FH-causing mutation12 monthsProportion of subjects with causative mutation in higher algorithm score groups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026